.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
UBS
McKinsey
Johnson and Johnson
Cantor Fitzgerald
Novartis
Julphar
Deloitte
Daiichi Sankyo
McKesson

Generated: November 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 078702

« Back to Dashboard
NDA 078702 describes CANDESARTAN CILEXETIL, which is a drug marketed by Sandoz, Macleods Pharms Ltd, Alembic Pharms Ltd, Apotex Inc, Zydus Pharms Usa Inc, Mylan Pharms Inc, and Dr Reddys Labs Ltd, and is included in nine NDAs. It is available from seven suppliers. Additional details are available on the CANDESARTAN CILEXETIL profile page.

The generic ingredient in CANDESARTAN CILEXETIL is candesartan cilexetil; hydrochlorothiazide. There are twenty-two drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the candesartan cilexetil; hydrochlorothiazide profile page.

Summary for 078702

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 078702

Suppliers and Packaging for NDA: 078702

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CANDESARTAN CILEXETIL
candesartan cilexetil
TABLET;ORAL 078702 ANDA Sandoz Inc 0781-5936 0781-5936-31 30 TABLET in 1 BOTTLE (0781-5936-31)
CANDESARTAN CILEXETIL
candesartan cilexetil
TABLET;ORAL 078702 ANDA Sandoz Inc 0781-5937 0781-5937-31 30 TABLET in 1 BOTTLE (0781-5937-31)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength4MG
Approval Date:May 3, 2013TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength8MG
Approval Date:May 3, 2013TE:ABRLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength16MG
Approval Date:May 3, 2013TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Colorcon
Deloitte
McKesson
Federal Trade Commission
Farmers Insurance
Julphar
Healthtrust
Accenture
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot